Literature DB >> 31174670

Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants.

Stephen P Yoon1, Dilraj S Grewal1, Atalie C Thompson1, Bryce W Polascik1, Cynthia Dunn2, James R Burke2, Sharon Fekrat3.   

Abstract

PURPOSE: Evaluate and compare the retinal microvasculature in the superficial capillary plexus (SCP) in Alzheimer's disease (AD), mild cognitive impairment (MCI), and cognitively intact controls using OCT angiography. OCT parameters were also compared.
DESIGN: Cross-sectional study. PARTICIPANTS: Seventy eyes from 39 AD participants, 72 eyes from 37 MCI participants, and 254 eyes from 133 control participants were enrolled.
METHODS: Participants were imaged using Zeiss Cirrus HD-5000 with AngioPlex (Carl Zeiss Meditec, Dublin, CA) and underwent cognitive evaluation with Mini-Mental State Examination. MAIN OUTCOME MEASURES: Vessel density (VD) and perfusion density (PD) in the SCP within the Early Treatment Diabetic Retinopathy Study 6-mm circle, 3-mm circle, and 3-mm ring were compared between groups. Foveal avascular zone (FAZ) area, central subfield thickness (CST), macular ganglion cell-inner plexiform layer (GC-IPL) thickness, and peripapillary retinal nerve fiber layer (RNFL) thickness were also compared.
RESULTS: Alzheimer's participants showed significantly decreased SCP VD and PD in the 3-mm ring (P = 0.001 and P = 0.002, respectively) and 3-mm circle (P = 0.003 and P = 0.004, respectively) and decreased SCP VD in the 6-mm circle (P = 0.047) compared with MCI and significantly decreased SCP VD and PD in the 3-mm ring (P = 0.008 and P = 0.004, respectively) and 3-mm circle (P = 0.015 and P = 0.009, respectively) and SCP PD in the 6-mm circle (P = 0.033) when compared with cognitively intact controls. There was no difference in SCP VD or PD between MCI and controls (P > 0.05). FAZ area and CST did not differ significantly between groups (P > 0.05). Alzheimer's participants showed significantly decreased GC-IPL thickness over the inferior (P = 0.032) and inferonasal (P = 0.025) sectors compared with MCI and significantly decreased GC-IPL thickness over the entire (P = 0.012), superonasal (P = 0.041), inferior (P = 0.004), and inferonasal (P = 0.006) sectors compared to controls. MCI participants showed significantly decreased temporal RNFL thickness (P = 0.04) compared with controls.
CONCLUSIONS: Alzheimer's participants showed significantly reduced macular VD, PD, and GC-IPL thickness compared with MCI and controls. Changes in the retinal microvasculature may mirror small vessel cerebrovascular changes in AD.
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31174670      PMCID: PMC6586560          DOI: 10.1016/j.oret.2019.02.002

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


  50 in total

1.  Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.

Authors:  Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane
Journal:  Alzheimers Dement       Date:  2018-08-08       Impact factor: 21.566

Review 2.  ZEISS Angioplex™ Spectral Domain Optical Coherence Tomography Angiography: Technical Aspects.

Authors:  Philip J Rosenfeld; Mary K Durbin; Luiz Roisman; Fang Zheng; Andrew Miller; Gillian Robbins; Karen B Schaal; Giovanni Gregori
Journal:  Dev Ophthalmol       Date:  2016-03-15

3.  Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Carol Yim-lui Cheung; Yi Ting Ong; Saima Hilal; M Kamran Ikram; Sally Low; Yi Lin Ong; N Venketasubramanian; Philip Yap; Dennis Seow; Christopher Li Hsian Chen; Tien Yin Wong
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Microvascular network alterations in the retina of patients with Alzheimer's disease.

Authors:  Carol Yim-Lui Cheung; Yi Ting Ong; M Kamran Ikram; Shin Yeu Ong; Xiang Li; Saima Hilal; Joseree-Ann S Catindig; Narayanaswamy Venketasubramanian; Philip Yap; Dennis Seow; Christopher P Chen; Tien Yin Wong
Journal:  Alzheimers Dement       Date:  2014-01-15       Impact factor: 21.566

5.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings.

Authors:  Bliss Elizabeth O'Bryhim; Rajendra S Apte; Nathan Kung; Dean Coble; Gregory P Van Stavern
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

Review 6.  Beta-amyloid, blood vessels, and brain function.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

7.  Alzheimer's disease: diagnostics, prognostics and the road to prevention.

Authors:  Iris Grossman; Michael W Lutz; Donna G Crenshaw; Ann M Saunders; Daniel K Burns; Allen D Roses
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

8.  Glaucoma, Alzheimer's disease, and Parkinson's disease: an 8-year population-based follow-up study.

Authors:  I-Chan Lin; Yuan-Hung Wang; Tsung-Jen Wang; I-Jong Wang; Yun-Dun Shen; Yun-Den Shen; Nai-Fang Chi; Li-Nien Chien
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

9.  Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease.

Authors:  Leonardo Provetti Cunha; Luciana Cheker Lopes; Luciana Virgínia Ferreira Costa-Cunha; Carolina Ferreira Costa; Leopoldo Antônio Pires; Ana Laura Maciel Almeida; Mário Luiz Ribeiro Monteiro
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

10.  Melanopsin retinal ganglion cell loss in Alzheimer disease.

Authors:  Chiara La Morgia; Fred N Ross-Cisneros; Yosef Koronyo; Jens Hannibal; Roberto Gallassi; Gaetano Cantalupo; Luisa Sambati; Billy X Pan; Kevin R Tozer; Piero Barboni; Federica Provini; Pietro Avanzini; Michele Carbonelli; Annalisa Pelosi; Helena Chui; Rocco Liguori; Agostino Baruzzi; Maya Koronyo-Hamaoui; Alfredo A Sadun; Valerio Carelli
Journal:  Ann Neurol       Date:  2015-12-18       Impact factor: 10.422

View more
  57 in total

1.  Retinal Biomarkers of Alzheimer Disease.

Authors:  Cecilia S Lee; Rajendra S Apte
Journal:  Am J Ophthalmol       Date:  2020-05-06       Impact factor: 5.258

2.  Dual-consistency semi-supervision combined with self-supervision for vessel segmentation in retinal OCTA images.

Authors:  Zailiang Chen; Yuchen Xiong; Hao Wei; Rongchang Zhao; Xuanchu Duan; Hailan Shen
Journal:  Biomed Opt Express       Date:  2022-04-21       Impact factor: 3.562

Review 3.  Role of Optical Coherence Tomography in Identifying Retinal Biomarkers in Frontotemporal Dementia: A Review.

Authors:  Omar Moinuddin; Nikhila S Khandwala; Kelly Z Young; Sanjana K Sathrasala; Sami J Barmada; Roger L Albin; Cagri G Besirli
Journal:  Neurol Clin Pract       Date:  2021-08

4.  Association between retinal markers and cognition in older adults: a systematic review.

Authors:  Varshanie Jeevakumar; Rebekah Sefton; Joyce Chan; Bamini Gopinath; Gerald Liew; Tejal M Shah; Joyce Siette
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

5.  Optical coherence tomography angiography in Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Andreas Katsimpris; Aristotelis Karamaounas; Anna Maria Sideri; John Katsimpris; Ilias Georgalas; Petros Petrou
Journal:  Eye (Lond)       Date:  2021-06-30       Impact factor: 4.456

6.  Cognitive decline in older adults: What can we learn from optical coherence tomography (OCT)-based retinal vascular imaging?

Authors:  Alison G Abraham; Xinxing Guo; Lubaina T Arsiwala; Yanan Dong; A Richey Sharrett; David Huang; Qisheng You; Liang Liu; Brandon J Lujan; Alexander Tomlinson; Thomas Mosley; Josef Coresh; Yali Jia; Aleksandra Mihailovic; Pradeep Y Ramulu
Journal:  J Am Geriatr Soc       Date:  2021-05-19       Impact factor: 7.538

Review 7.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

8.  Retinal Microvascular Alterations as the Biomarkers for Alzheimer Disease: Are We There Yet?

Authors:  Hong Jiang; Jianhua Wang; Bonnie E Levin; Bernard S Baumel; Christian J Camargo; Joseph F Signorile; Tania Rundek
Journal:  J Neuroophthalmol       Date:  2021-06-01       Impact factor: 4.415

9.  A Systematic Review and Meta-Analysis of Retinal Microvascular Features in Alzheimer's Disease.

Authors:  Qifang Jin; Yiming Lei; Ruoxin Wang; Huiying Wu; Kaibao Ji; Ling Ling
Journal:  Front Aging Neurosci       Date:  2021-06-29       Impact factor: 5.750

Review 10.  Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer's Disease.

Authors:  Shaunt Fereshetian; Joshua S Agranat; Nicole Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  J Alzheimers Dis Rep       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.